Nosocomial Tracheobronchitis and Pneumonia Continuum - Target for Inhaled Antibiotics?

Title:Nosocomial Tracheobronchitis and Pneumonia Continuum - Target for Inhaled Antibiotics?

Volume: 14 Issue: 3

Author(s): Artem Kuzovlev*, Aslan Shabanov, Tamara Smelaya, Arkady Goloubev, Viktor Moroz, Sergey Petrikov and Andrey Grechko

Affiliation:

• Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow,Russian Federation

Keywords: Colistin, inhaled antibiotics, nosocomial pneumonia, nosocomial tracheobronchitis, tobramycin, respiratory tract.

Abstract: The aim of this mini-review is to highlight the current state of the problem of nosocomial pneumonia and nosocomial tracheobronchitis in critically ill patients. The important concepts for nosocomial tracheobronchitis, novel genetic and molecular biomarkers of nosocomial pneumonia and nosocomial tracheobronchitis and the role of inhaled antibiotics in the treatment of this condition and their ability to prevent the development of nosocomial pneumonia are discussed.

Cite this article as:

Kuzovlev Artem*, Shabanov Aslan, Smelaya Tamara, Goloubev Arkady, Moroz Viktor, Petrikov Sergey and Grechko Andrey, Nosocomial Tracheobronchitis and Pneumonia Continuum - Target for Inhaled Antibiotics?, Current Respiratory Medicine Reviews 2018; 14 (3) . https://dx.doi.org/10.2174/1573398X14666181019121945